quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:32:03·55d
INSIDERFiling
VolitionRX Limited logo

President and CEO Reynolds Cameron John was granted 486,000 shares, increasing direct ownership by 18% to 3,115,547 units (SEC Form 4)

VNRX· VolitionRX Limited
Health Care
Original source

Companies

  • VNRX
    VolitionRX Limited
    Health Care

Recent analyst ratings

  • Apr 8UpdateH.C. Wainwright$2.50
  • Feb 1UpdateThe Benchmark Company-
  • Feb 17UpdateCantor Fitzgerald$7.00
  • Nov 16UpdateAegis Capital$9.00

Related

  • SEC1d
    VolitionRX Limited filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits
  • PR1d
    VolitionRx Announces Acceptance of Compliance Plan by NYSE American
  • PR4d
    Volition Launches rNuQ™ Webshop Broadening Product Range
  • SEC6d
    VolitionRX Limited filed SEC Form 8-K: Other Events, Submission of Matters to a Vote of Security Holders
  • SEC22d
    VolitionRX Limited filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
  • SEC23d
    SEC Form 10-K filed by VolitionRX Limited
  • SEC23d
    VolitionRX Limited filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • PR23d
    VolitionRx Limited Announces Full Fiscal Year 2025 Financial Results and Business Update
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022